Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Metalmark Capital on the deal. Metalmark Capital executed its investment of up to $50 million in Orgenesis’s U.S.-based point of care services subsidiary, Morgenesis...
You must be a Standard 1 Year member to access this content.
Cravath represented QUALCOMM Incorporated, while Davis Polk advised the representatives of the several underwriters in the offering. Qualcomm Incorporated executed its SEC-registered offering of $700 million aggregate...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Molded Devices on the deal, while Schauenburg Hose Technology Group, GlobalMed Inc. (Canada) and Schauenburg-Truplast (China) were represented by Fasken Martineau DuMoulin LLP....
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented NextGen Healthcare, while Davis Polk advised J.P. Morgan Securities LLC, the representative of the initial purchasers in the offering. NextGen Healthcare, Inc....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters. Denali Therapeutics, a biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini and Honigman advised Prime Medicine on the deal, while Davis Polk advised the joint book-running managers. Prime Medicine, Inc., a biotechnology company committed to...
You must be a Standard 1 Year member to access this content.
Davis Polk advised European Biotech Acquisition Corp. on the deal while Cooley and Vischer represented Oculis. European Biotech Acquisition Corp. (EBAC), a SPAC, signed its $200 million...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Immatics on the offering while Covington represented underwriters. Immatics N.V. executed its $110 million SEC-registered offering of ordinary shares. The ordinary shares are...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the placement agent, BofA Securities, Inc., in the offering. Solid Biosciences, Inc. executed its private placement of $75 million of common stock. The financing is...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representative of the underwriters in the offering. Gamida Cell Ltd. announced the $20 million SEC-registered follow-on offering of 12,905,000 ordinary shares. The ordinary shares...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Medtronic Global Holdings, while Davis Polk advised the representatives of the several underwriters in the offering. Medtronic Global Holdings S.C.A. executed its offering of...
You must be a Standard 1 Year member to access this content.
